findmyKOL

Belal Firwana, MD

Basic profile

Missouri Baptist Medical Center

ORCIDNPI
RegionSaint Louis, MO · MidwestSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Belal Firwana is an Oncology physician affiliated with Missouri Baptist Medical Center. OpenAlex indexes 82 publications with 4,886 citations (h-index 29).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
82publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,886citations

Total citations across indexed works.

29h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3015 N Ballas Rd
Saint Louis, MO 63131

Telephone

314-996-5512

Provider last certified this registry record 7 Aug 2024.

View the NPPES registry record

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    31.8%
    Aromatase Inhibitor18.3%
    Anastrozole66%Letrozole28%Exemestane6%
    Part D<11 patients
    Antimetabolite9.5%
    Hydroxyurea100%
    Part D27 patients

    + 1 more class in this area

  • Nervous system

    22.6%
    Opioid Agonist9.3%
    Oxycodone Hcl51%Tramadol Hcl20%Oxycodone-Acetaminophen19%Morphine Sulfate Er10%
    Part D<11 patients
    Phenothiazine5.4%
    Prochlorperazine Maleate100%
    Part D43 patients

    + 4 more classes in this area

  • Blood & clotting

    13.9%
    Factor Xa inhibitor12.9%
    Eliquis68%Xarelto32%
    Part D18 patients
    P2Y12 inhibitor1%
    Brilinta100%
    Part D<11 patients
Where care is delivered (Part B)72% facility · 28% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”